• News
  • SAN DIEGO
  • BioTech

Santarus launches colitis drug

Santarus Inc., a specialty biotech company in Carmel Valley, has begun the U.S. launch of Uceris, a treatment for patients with mild or moderate ulcerative colitis.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Santarus Inc.

Company Website

10590 W. Ocean Air Drive., Suite 200
San Diego, CA 92130

Santarus Inc. Executive(s):

Gerald Proehl

  • Chief Executive Officer, President

Related Videos

Entrepreneur Of The Year 2013 semifinalist: Gerald Proehl

May 7, 2013 -- George Chamberlin speaks with Gerald Proehl, director/president/CEO of Santarus Inc., about the highs and lows of operating a biotech company. Proehl is a semifinalist in the Ernst & Young Entrepreneur Of The Year 2013 San Diego awards.

View all the videos in this series.

Similar Companies

NAICS - 325412 - Pharmaceutical Preparation Manufacturing
SIC - 2835 - IN VITRO AND IN VIVO DIAGNOSTIC SUBSTANCES
SIC - 2834 - PHARMACEUTICAL PREPARATIONS
NAICS - 424210 - Drugs and Druggists' Sundries Merchant Wholesalers
SIC - 5122 - DRUGS, DRUG PROPRIETARIES, AND DRUGGISTS' SUNDRIES
Subscribe Today!